Breaking News Instant updates and real-time market news.

2020-11-23 12:53:11 CBWBF Canadian Western Bank $0.00 / + (+0.00%) 12:53 11/23/20 11/23 12:53 11/23/20 12:53	Canadian Western Bank price target raised to C$33 from C$29 at Scotiabank Scotiabank analyst Sumit Malhotra raised the firm's price target on Canadian Western Bank to C$33 from C$29.
CBWBF Canadian Western Bank $0.00 / + (+0.00%) 11/18/20 National Bank Canadian Western Bank price target raised to C$30 from C$28 at National Bank 10/28/20 Raymond James Canadian Western Bank initiated with an Outperform at Raymond James 09/09/20 Barclays Canadian Western Bank price target raised to C$30 from C$27 at Barclays 09/01/20 Desjardins Canadian Western Bank price target raised to C$30 from C$26 at Desjardins

2020-11-23 12:53:11

CBWBF

Canadian Western Bank

$0.00 / + (+0.00%)

12:53

11/23/20

11/23

12:53

11/23/20

12:53

Canadian Western Bank price target raised to C$33 from C$29 at Scotiabank

Scotiabank analyst Sumit Malhotra raised the firm's price target on Canadian Western Bank to C$33 from C$29.

CBWBF Canadian Western Bank

$0.00 / + (+0.00%)

11/18/20 National Bank: Canadian Western Bank price target raised to C$30 from C$28 at National Bank

10/28/20 Raymond James: Canadian Western Bank initiated with an Outperform at Raymond James

09/09/20 Barclays: Canadian Western Bank price target raised to C$30 from C$27 at Barclays

09/01/20 Desjardins: Canadian Western Bank price target raised to C$30 from C$26 at Desjardins

TODAY'S FREE FLY STORIES

General news	U.S. jobless claims preview » 02:05 01/21/21 01/21 02:05 01/21/21 02:05 U.S. jobless claims… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	Asian Market Update: » 01:55 01/21/21 01/21 01:55 01/21/21 01:55 Asian Market Update: Risk… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	U.S. Philly Fed preview » 01:55 01/21/21 01/21 01:55 01/21/21 01:55 U.S. Philly Fed preview:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	U.S. housing starts preview » 01:55 01/21/21 01/21 01:55 01/21/21 01:55 U.S. housing starts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	BoJ left main policy settings unchanged » 01:55 01/21/21 01/21 01:55 01/21/21 01:55 BoJ left main policy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Syndicate	Orchid Island Capital 7.6M share Spot Secondary priced at $5.30 » 20:44 01/20/21 01/20 20:44 01/20/21 20:44 ORC Orchid Island Capital $5.52 / +0.05 (+0.91%) The deal priced below the… The deal priced below the last closing price of $5.53. JPMorgan is acting as sole book running manager for the offering. ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly ORC Orchid Island Capital $5.52 / +0.05 (+0.91%) 10/30/20 Ladenburg Orchid Island Capital upgraded to Buy from Neutral at Ladenburg ORC Orchid Island Capital $5.52 / +0.05 (+0.91%) 01/14/21 Orchid Island Capital sees Q4 EPS 23c, consensus 24c 21 Jan ORC Orchid Island Capital $5.52 / +0.05 (+0.91%) 01/20/21 Fly Intel: After-Hours Movers
Upgrade	Tellurian upgraded to Outperform from Peer Perform at Wolfe Research » 20:41 01/20/21 01/20 20:41 01/20/21 20:41 TELL Tellurian $2.48 / -0.105 (-4.06%) Wolfe Research analyst… Wolfe Research analyst Sam Margolin upgraded Tellurian to Outperform from Peer Perform with a $5 price target. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Tellurian surges as Petronet reportedly renews investment agreement TELL Tellurian $2.48 / -0.105 (-4.06%) 06/10/20 Fly Intel: Top five analyst initiations 06/10/20 Roth Capital Tellurian initiated with a Buy at Roth Capital 06/01/20 Stifel Tellurian downgraded to Sell from Hold at Stifel 04/21/20 Evercore ISI Tellurian downgraded to In Line from Outperform at Evercore ISI TELL Tellurian $2.48 / -0.105 (-4.06%) 08/05/20 Tellurian reports Q2 EPS (53c), consensus (11c) TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Petronet renews deal over $2.5B investment in Tellurian project, Reuters says TELL Tellurian $2.48 / -0.105 (-4.06%) 07/21/20 Fly Intel: Wall Street's top stories for Tuesday 03/01/21 26th Annual Energy Virtual Summit TELL Tellurian $2.48 / -0.105 (-4.06%) 11/05/20 Tellurian options imply 41.6% move in share price post-earnings 11/05/20 Largest borrow rate increases among liquid names 11/03/20 Largest borrow rate increases among liquid names 10/27/20 Largest borrow rate increases among liquid names
Periodicals	Notable companies reporting before tomorrow's open » 20:25 01/20/21 01/20 20:25 01/20/21 20:25 UNP Union Pacific $218.16 / +2.92 (+1.36%) , TFC Truist Financial $51.61 / -0.52 (-1.00%) , TRV Travelers $145.04 / +1.5 (+1.05%) , FITB Fifth Third $31.32 / -0.75 (-2.34%) , NTRS Northern Trust $94.81 / -2.63 (-2.70%) , KEY KeyCorp $18.29 / -0.26 (-1.40%) Notable companies… Notable companies reporting before tomorrow's open, with earnings consensus, include Union Pacific (UNP), consensus $2.23... Truist Financial (TFC), consensus 97c... Travelers (TRV), consensus $3.18... Fifth Third Bancorp (FITB), consensus 69c... Northern Trust (NTRS), consensus $1.49... KeyCorp (KEY), consensus 43c. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UNP TRV TFC NTRS KEY FITB UNP Union Pacific $218.16 / +2.92 (+1.36%) 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/10/21 Fly Intel: Top five weekend stock stories 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 TRV Travelers $145.04 / +1.5 (+1.05%) 12/03/20 Travelers acquires InsuraMatch from Plymouth Rock Group, terms not disclosed 10/20/20 Travelers CEO says net written premiums in Q3 up nearly 3% 10/20/20 Travelers reports Q3 return on equity of 12.1%, core return on equity 13.5% 10/20/20 Travelers reports Q3 adj. book value per share $94.89 TFC Truist Financial $51.61 / -0.52 (-1.00%) 01/06/21 Truist Financial sells institutional retirement business to OneDigital 12/23/20 Truist Financial announces $2B share repurchase plan 12/08/20 Truist Financial sees achieving 65% of $1.6B net cost savings by 4Q21 12/08/20 Truist Financial: PPP forgiveness could be close to 90% NTRS Northern Trust $94.81 / -2.63 (-2.70%) 12/01/20 Northern Trust selected by Sands Capital to provide UCITS fund administration 11/09/20 Northern Trust selected by Emerald to provide fund administration 10/12/20 Northern Trust selected by M&SPT to provide asset servicing solutions KEY KeyCorp $18.29 / -0.26 (-1.40%) 12/03/20 Accenture names former KeyCorp CEO Mooney to board 10/21/20 KeyCorp expects to be back on path to achieving LT targets 10/21/20 KeyCorp has decided to discontinue originating indirect auto loans 10/21/20 KeyCorp sees Q4 net interest income up low single digits FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/04/21 Fifth Third completes acquisition of Hammond Hanlon Camp 12/07/20 Fifth Third Bank announces $2.8B investment to accelerate racial equity 11/22/20 Fly Intel: Top five weekend stock stories 11/16/20 Fifth Third introduces Fifth Third Cash/Back Card UNP TFC TRV FITB NTRS KEY UNP Union Pacific $218.16 / +2.92 (+1.36%) 01/20/21 Susquehanna Railroad recovery expected to continue in 2021, says Susquehanna 01/15/21 Raymond James Union Pacific price target raised to $250 from $220 at Raymond James 01/12/21 JPMorgan Union Pacific price target raised to $216 from $212 at JPMorgan 01/11/21 Bernstein Union Pacific upgraded to Outperform from Market Perform at Bernstein TFC Truist Financial $51.61 / -0.52 (-1.00%) 01/07/21 Baird Truist Financial downgraded to Neutral from Outperform at Baird 01/07/21 Jefferies Jefferies downgrades 'more defensive' Truist Financial to Hold 01/07/21 Jefferies Truist Financial downgraded to Hold from Buy at Jefferies 01/06/21 Deutsche Bank Truist Financial price target raised to $56 from $46 at Deutsche Bank TRV Travelers $145.04 / +1.5 (+1.05%) 01/04/21 JPMorgan Travelers price target raised to $136 from $129 at JPMorgan 11/27/20 MKM Partners Travelers price target raised to $160 from $140 at MKM Partners 11/17/20 Barclays Travelers initiated with an Overweight at Barclays 10/29/20 BofA Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed FITB Fifth Third $31.32 / -0.75 (-2.34%) 01/07/21 Goldman Sachs Fifth Third upgraded to Buy from Neutral at Goldman Sachs 01/06/21 Deutsche Bank Fifth Third price target raised to $30 from $24 at Deutsche Bank 01/04/21 Barclays Fifth Third price target raised to $37 from $28 at Barclays 12/07/20 Evercore ISI Fifth Third upgraded to In Line from Underperform at Evercore ISI NTRS Northern Trust $94.81 / -2.63 (-2.70%) 01/12/21 BofA BofA cuts Northern Trust to Underperform on muted growth, elevated valuation 01/12/21 BofA Northern Trust downgraded to Underperform from Neutral at BofA 01/11/21 Piper Sandler Northern Trust price target raised to $115 from $100 at Piper Sandler 01/05/21 Goldman Sachs Northern Trust downgraded to Sell from Neutral at Goldman Sachs KEY KeyCorp $18.29 / -0.26 (-1.40%) 01/06/21 Deutsche Bank KeyCorp price target raised to $18 from $14 at Deutsche Bank 01/04/21 Barclays KeyCorp price target raised to $20 from $15 at Barclays 10/26/20 Fly Intel: Top five analyst downgrades 10/26/20 Wedbush KeyCorp downgraded to Neutral on valuation, headwinds at Wedbush UNP TRV TFC NTRS KEY FITB UNP Union Pacific $218.16 / +2.92 (+1.36%) 10/22/20 Union Pacific reports Q3 EPS $2.01, consensus $2.05 10/21/20 Notable companies reporting before tomorrow's open 07/23/20 Union Pacific reports Q2 EPS $1.67, consensus $1.55 TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Travelers reports Q3 core EPS $3.12, consensus $3.00 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) TFC Truist Financial $51.61 / -0.52 (-1.00%) 10/15/20 Truist Financial reports Q3 adj. EPS 97c, consensus 89c 10/14/20 Notable companies reporting before tomorrow's open NTRS Northern Trust $94.81 / -2.63 (-2.70%) 10/21/20 Northern Trust reports Q3 EPS $1.32, consensus $1.38 07/22/20 Northern Trust reports Q2 EPS $1.46, consensus $1.37 KEY KeyCorp $18.29 / -0.26 (-1.40%) 10/21/20 KeyCorp reports Q3 EPS 41c, consensus 37c 10/20/20 Notable companies reporting before tomorrow's open 07/22/20 KeyCorp reports Q2 EPS 16c, consensus 8c FITB Fifth Third $31.32 / -0.75 (-2.34%) 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 07/23/20 Fifth Third reports Q2 EPS 23c with items, consensus 20c UNP TFC UNP Union Pacific $218.16 / +2.92 (+1.36%) 01/20/21 Notable companies reporting before tomorrow's open 01/09/21 Some century-old stocks still deliver, Barron's says 08/14/20 Union Pacific issues second spot rate increase in California, JOC.com reports TFC Truist Financial $51.61 / -0.52 (-1.00%) 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 09/26/20 Deal synergies should lift Truist Financial, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says UNP TRV TFC KEY FITB UNP Union Pacific $218.16 / +2.92 (+1.36%) 10/22/20 Fly Intel: Pre-market Movers TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: Wall Street's top stories for Thursday TFC Truist Financial $51.61 / -0.52 (-1.00%) 10/15/20 Fly Intel: Pre-market Movers KEY KeyCorp $18.29 / -0.26 (-1.40%) 10/26/20 Apple coverage reinstatement, KeyCorp downgrade among top calls on Wall Street 07/22/20 Fly Intel: Pre-market Movers FITB Fifth Third $31.32 / -0.75 (-2.34%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 03/01/21 26th Annual Energy Virtual Summit 08:00 Today Truist Financial - TFC 08:45 Today Union Pacific - UNP 09:00 Today Fifth Third - FITB 09:00 Today Travelers - TRV 10:00 Today KeyCorp - KEY 10:00 Today Northern Trust - NTRS 01/22/21 Mapping Your Corporate Social Responsibility UNP KEY UNP Union Pacific $218.16 / +2.92 (+1.36%) 11/10/20 Union Pacific put volume heavy and directionally bearish 08/03/20 Union Pacific put volume heavy and directionally bearish KEY KeyCorp $18.29 / -0.26 (-1.40%) 08/11/20 KeyCorp call volume above normal and directionally bullish
Downgrade	BJ's Restaurants downgraded to Hold from Buy at Deutsche Bank » 20:11 01/20/21 01/20 20:11 01/20/21 20:11 BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) Deutsche Bank analyst… Deutsche Bank analyst Brian Mullan downgraded BJ's Restaurants to Hold from Buy with a $50 price target. ShowHide Related Items >><< Company News Street Research Earnings On The Fly BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 09/01/20 Four Corners announces acquisition of a BJ's Restaurant property for $3.1M 07/23/20 BJ's Restaurants reports Q2 comparable sales decline of 57.2% BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 01/07/21 Stephens BJ's Restaurants upgraded to Overweight on casual dining 'boom' at Stephens 01/07/21 Stephens BJ's Restaurants upgraded to Overweight from Equal Weight at Stephens 12/17/20 Wells Fargo BJ's Restaurants upgraded to Overweight from Equal Weight at Wells Fargo 12/16/20 Fly Intel: Top five analyst upgrades BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 10/22/20 BJ's Restaurants reports Q3 EPS (30c), consensus (71c) 07/23/20 BJ's Restaurants reports Q2 EPS ($1.38), consensus ($1.95) BJRI BJ's Restaurants $47.36 / -1.2 (-2.47%) 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 07/23/20 Fly Intel: After-Hours Movers
Syndicate	Dyne Therapeutics 6M share Secondary priced at $28.00 » 20:09 01/20/21 01/20 20:09 01/20/21 20:09 DYN Dyne Therapeutics $28.67 / +0.08 (+0.28%) The deal priced below the… The deal priced below the last closing price of $28.53. JPMorgan, Jefferies, Piper Sandler and Stifel are acting as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DYN Dyne Therapeutics $28.67 / +0.08 (+0.28%) 01/10/21 Dyne Therapeutics announced new preclinical data from DM1 program 09/28/20 Citadel Advisors takes 6.5% passive stake in Dyne Therapeutics DYN Dyne Therapeutics $28.67 / +0.08 (+0.28%) 01/07/21 Piper Sandler Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper 10/12/20 Jefferies Dyne Therapeutics initiated with a Buy at Jefferies 10/12/20 JPMorgan Dyne Therapeutics initiated with an Overweight at JPMorgan 10/12/20 Stifel Dyne Therapeutics initiated with a Buy at Stifel DYN Dyne Therapeutics $28.67 / +0.08 (+0.28%) 11/05/20 Dyne Therapeutics reports Q3 EPS ($2.01), consensus (87c) 21 Jan 17 Sep DYN Dyne Therapeutics $28.67 / +0.08 (+0.28%) 09/28/20 Fly Intel: After-Hours Movers 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever

Syndicate	Chimerix 11.765M share Secondary priced at $8.50 » 20:06 01/20/21 01/20 20:06 01/20/21 20:06 CMRX Chimerix $9.13 / +1.05 (+13.00%) The deal priced below the… The deal priced below the last closing price of $9.13. Jefferies and Cowen are acting as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CMRX Chimerix $9.13 / +1.05 (+13.00%) 01/08/21 Chimerix acquires Oncoceutics for $78M 12/07/20 Chimerix announces FDA acceptance of NDA for brincidofovir 11/05/20 Chimerix announces expected upcoming milestones 08/10/20 Chimerix announces expected upcoming milestones CMRX Chimerix $9.13 / +1.05 (+13.00%) 01/11/21 H.C. Wainwright Chimerix price target raised to $16 from $7 at H.C. Wainwright 05/21/20 JonesTrading Chimerix initiated with a Buy at JonesTrading CMRX Chimerix $9.13 / +1.05 (+13.00%) 11/05/20 Chimerix reports Q3 EPS (18c), consensus (17c) 08/10/20 Chimerix reports Q2 EPS (16c), consensus (17c) 21 Jan CMRX Chimerix $9.13 / +1.05 (+13.00%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 12/07/20 Fly Intel: Pre-market Movers 04/07/21 PDUFA Date for Brincidofovir
Syndicate	Dream Finders Homes 9.6M share IPO priced at $13.00 » 20:04 01/20/21 01/20 20:04 01/20/21 20:04 DFH Dream Finders Homes $0.00 / + (+0.00%) The deal priced inside… The deal priced inside the $12.00-$15.00 target range. BofA, RBC Capital and BTIG are acting as joint book running managers for the offering. ShowHide Related Items >><< Syndicate 21 Jan
Hot Stocks	Denali Therapeutics CFO sells 50K shares of common stock » 19:59 01/20/21 01/20 19:59 01/20/21 19:59 DNLI Denali Therapeutics $77.47 / +1.58 (+2.08%) In a regulatory filing,… In a regulatory filing, Denali Therapeutics disclosed that its CFO Steve Krognes sold 50K shares of common stock on January 15th in a total transaction size of $3.57M, reducing his stake by about 5%. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events DNLI Denali Therapeutics $77.47 / +1.58 (+2.08%) 01/11/21 Denali Therapeutics appoints Nancy Thornberry to board of directors 01/08/21 Denali plans to file IND or CTA for DNL919 in late 2021/early 2022 01/08/21 Denali Therapeutics plans to file IND or CTA for DNL593 in late 2021 01/08/21 Denali says Sanofi plans to initiate Phase 2 trial of DNL758 in early 2021 DNLI Denali Therapeutics $77.47 / +1.58 (+2.08%) 11/11/20 JPMorgan Denali Therapeutics price target raised to $65 from $45 at JPMorgan 11/11/20 H.C. Wainwright Denali Therapeutics price target raised to $80 from $65 at H.C. Wainwright 11/10/20 Goldman Sachs Denali Therapeutics price target raised to $81 from $61 at Goldman Sachs 11/06/20 H.C. Wainwright Denali Therapeutics price target raised to $65 from $45 at H.C. Wainwright DNLI Denali Therapeutics $77.47 / +1.58 (+2.08%) 11/05/20 Denali Therapeutics reports Q3 EPS (54c) vs. (48c) last year 08/07/20 Denali Therapeutics reports Q2 EPS (56c), consensus (60c) 29 Jan DNLI Denali Therapeutics $77.47 / +1.58 (+2.08%) 09/28/20 Fly Intel: After-Hours Movers 08/06/20 Fly Intel: Wall Street's top stories for Thursday 08/06/20 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021
Hot Stocks	Caesars director sells 20K shares of common stock » 19:58 01/20/21 01/20 19:58 01/20/21 19:58 CZR Caesars $80.07 / -0.62 (-0.77%) In a regulatory filing,… In a regulatory filing, Caesars disclosed that its General Counsel Edmund Quatmann sold 20K shares of common stock on January 19th in a total transaction size of $1.63M, reducing his stake by about 41%. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CZR Caesars $80.07 / -0.62 (-0.77%) 01/20/21 Nevada extends casino capacity limits through February 14 01/13/21 New Jersey reports December gaming revenue up 8.9% to $312.9M 01/06/21 New York seeking proposals for mobile sports wagering operator 01/06/21 Cuomo seeks 'different model for sports betting' where state gets the sales CZR Caesars $80.07 / -0.62 (-0.77%) 01/14/21 Truist Caesars price target raised to $92 from $85 at Truist 01/14/21 KeyBanc KeyBanc bullish on Caesars, initiates with an Overweight 01/13/21 KeyBanc Caesars initiated with an Overweight at KeyBanc 01/06/21 Morgan Stanley New York sports betting comments hint at higher tax rate, says Morgan Stanley CZR Caesars $80.07 / -0.62 (-0.77%) 11/05/20 Caesars reports Q3 EPS ($6.09), consensus ($2.15) 11/05/20 Notable companies reporting after market close 08/06/20 Caesars reports Q2 EPS ($1.25), consensus ($1.01) 29 Sep CZR Caesars $80.07 / -0.62 (-0.77%) 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games 12/26/20 Caesars, Wynn among leisure stocks to play rebound, Barron's says 12/18/20 Ohio sports betting bill fails to reach Senate floor, Play Ohio reports 12/09/20 NY online sports betting could soon be legal, PlayNY says CZR Caesars $80.07 / -0.62 (-0.77%) 01/15/21 Bet On It: New Jersey handle ranks highest in 2020 01/08/21 Bet On It: New York warming up to online sports betting 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 12/31/20 Bet On It: Rush Street Interactive completes SPAC merger, exceeds expectations 02/25/21 Caesars - CZR CZR Caesars $80.07 / -0.62 (-0.77%) 11/24/20 Caesars call volume above normal and directionally bullish 09/08/20 Caesars put volume heavy and directionally bearish 09/03/20 Caesars call volume above normal and directionally bullish
Hot Stocks	Workday CFO sells 10.5K share of common stock » 19:56 01/20/21 01/20 19:56 01/20/21 19:56 WDAY Workday $226.77 / +5.97 (+2.70%) In a regulatory filing,… In a regulatory filing, Workday disclosed that its CFO Robynne Sisco sold 10.5K shares of common stock on January 15th in a total transaction size of $2.37M, reducing her stake by about 7%. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options WDAY Workday $226.77 / +5.97 (+2.70%) 01/14/21 Workday launches COVID-19 vaccine management solution 12/14/20 Ceridian appoints Eric Glass as chief communciations officer 11/19/20 Workday jumps 5% to $242 after Q3 earnings beat, FY21 guidance update 09/09/20 Workday announces VIBE Central, VIBE Index offerings WDAY Workday $226.77 / +5.97 (+2.70%) 01/11/21 Piper Sandler Bill.com price target raised to $140 from $120 at Piper Sandler 12/16/20 BofA Workday reinstated with a Buy at BofA 12/16/20 BofA Workday reinstated with a Buy at BofA 11/25/20 Jefferies Anaplan price target raised to $70 from $65 at Jefferies WDAY Workday $226.77 / +5.97 (+2.70%) 11/19/20 Workday ups FY21 subscription revenue view to $3.77B-$3.78B from $3.73B-$3.74B 11/19/20 Workday reports Q3 EPS 86c, consensus 67c 11/19/20 Notable companies reporting after market close 08/27/20 Workday sees Q3 subscription revenue $948M-$950M WDAY Workday $226.77 / +5.97 (+2.70%) 12/16/20 Microsoft reinstatement, Spotify downgrade among top calls on Wall Street 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 11/20/20 Fly Intel: Wall Street's top stories for Friday 11/20/20 Fly Intel: Wall Street's top stories at midday WDAY Workday $226.77 / +5.97 (+2.70%) 11/19/20 Workday options imply 7.7% move in share price post-earnings 08/20/20 Workday call volume above normal and directionally bullish

Hot Stocks	Dynatrace CEO sells 55K shares of common stock » 19:54 01/20/21 01/20 19:54 01/20/21 19:54 DT Dynatrace $47.33 / +3.55 (+8.11%) In a regulatory filing,… In a regulatory filing, Dynatrace disclosed that its CEO John Van Siclen sold 50K shares of common stock on January 15th in a total transaction size of $2.37M, reducing his stake by about 4%. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events DT Dynatrace $47.33 / +3.55 (+8.11%) 12/17/20 Dynatrace CEO sells 55K shares of common stock 11/30/20 Dynatrace announces expanded partnership with SAP DT Dynatrace $47.33 / +3.55 (+8.11%) 01/19/21 Truist Dynatrace initiated with a Buy at Truist 12/30/20 Fly Intel: Top five analyst calls 12/29/20 BTIG Dynatrace initiated with a Buy at BTIG 12/17/20 Rosenblatt Dynatrace initiated with Buy, $48 target at Rosenblatt DT Dynatrace $47.33 / +3.55 (+8.11%) 10/28/20 Dynatrace raises FY21 adj. EPS view to 55c-57c from 46c-49c, consensus 48c 10/28/20 Dynatrace sees Q3 adjusted EPS 12c-13c, consensus 13c 10/28/20 Dynatrace reports Q2 adjusted EPS 18c, consensus 10c 10/27/20 Notable companies reporting before tomorrow's open 09 Dec 03 Aug 03 Jun 21 Feb DT Dynatrace $47.33 / +3.55 (+8.11%) 10/28/20 Fly Intel: Pre-market Movers 08/10/20 Fly Insider: Axis Capital, Carvana among week's notable insider trades 07/29/20 Fly Intel: Pre-market Movers 02/03/21 Dynatrace - DT
Recommendations	Rolls-Royce price target raised to 130 GBp from 110 GBp at Jefferies » 19:47 01/20/21 01/20 19:47 01/20/21 19:47 RYCEY Rolls-Royce $0.00 / + (+0.00%) Jefferies analyst Sandy… Jefferies analyst Sandy Morris raised the firm's price target on Rolls-Royce to 130 GBp from 110 GBp and keeps a Buy rating on the shares. The analyst notes that by mid-2021, COVID vaccine, testing, and Digital Health Pass will be effective in driving a strong recovery in travel. Morris adds that flying hours should also exit FY21 "at a good rate", and growth will return to civil aerospace. ShowHide Related Items >><< Company News Street Research Periodicals RYCEY Rolls-Royce $0.00 / + (+0.00%) 01/19/21 Altair signs MoU with Rolls-Royce Germany 12/02/20 Rolls-Royce, Infosys announce aerospace engineering partnership in India 09/24/20 Rolls-Royce awarded $197.04M Navy contract modification 08/11/20 Rolls-Royce finds indications of wear in small number of Trent XWB engines RYCEY Rolls-Royce $0.00 / + (+0.00%) 01/14/21 Societe Generale Rolls-Royce resumed with a Sell at Societe Generale 01/08/21 Morgan Stanley Rolls-Royce price target lowered to 109 GBp from 132 GBp at Morgan Stanley 12/15/20 Panmure Gordon Rolls-Royce downgraded to Sell from Hold at Panmure Gordon 12/14/20 Berenberg Rolls-Royce price target lowered to 140 GBp from 250 GBp at Berenberg RYCEY Rolls-Royce $0.00 / + (+0.00%) 10/26/20 Rolls-Royce could temporarily close factories as it braces for strike, FT says 10/01/20 Rolls-Royce plans to raise $6.5B to deal with COVID-19 cash crunch, Reuters says 09/30/20 Rolls-Royce calls off talks with sovereign funds, Sky News reports 09/21/20 Rolls-Royce in talks to raise GBP2.5B from investors in October, FT reports
Syndicate	Athira Pharma 4M share Secondary priced at $22.50 » 19:43 01/20/21 01/20 19:43 01/20/21 19:43 ATHA Athira Pharma $24.35 / -1.81 (-6.92%) The deal priced below the… The deal priced below the last closing price of $24.32. Goldman Sachs, Jefferies, Stifel and JMP Securities are acting as joint book running managers for the offering. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ATHA Athira Pharma $24.35 / -1.81 (-6.92%) 12/14/20 Athira says ATH platform can potentially address several clinical applications 12/14/20 LIFT-AD Phase 2/3, ACT-AD patient dosing among 2020 milestones, Athira says 12/14/20 Athira Pharma CEO says timelines 'remained on track' despite COVID 12/14/20 Urgent need remains for Alzheimer's treatment, Athira CEO says ATHA Athira Pharma $24.35 / -1.81 (-6.92%) 10/13/20 Jefferies Athira Pharma initiated with a Buy at Jefferies 10/13/20 JMP Securities Athira Pharma initiated with an Outperform at JMP Securities 10/13/20 Stifel Athira Pharma initiated with a Buy at Stifel 10/13/20 Goldman Sachs Athira Pharma initiated with a Buy at Goldman Sachs ATHA Athira Pharma $24.35 / -1.81 (-6.92%) 11/12/20 Athira Pharma reports Q EPS ($1.12), consensus (25c) 21 Jan 18 Sep ATHA Athira Pharma $24.35 / -1.81 (-6.92%) 12/14/20 Meet Athira Pharma: A Fly exclusive interview with CEO Leen Kawas 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever
Periodicals	Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says » 19:14 01/20/21 01/20 19:14 01/20/21 19:14 PFE Pfizer $36.48 / -0.26 (-0.71%) , BNTX BioNTech $103.17 / -1.805 (-1.72%) Hong Kong is set to… Hong Kong is set to approve the COVID vaccine manufactured by Pfizer (PFE) and BioNTech (BNTX), South China Morning Post's Elizabeth Cheung and Danny Lee write, citing a source. The report states that with the selection of Kwai Chung warehouse to store the vials, Hong Kong's Health secretary Sophia Chan could approve the use of the vaccine this week. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $36.48 / -0.26 (-0.71%) 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/14/21 Pfizer says FDA approves supplemental NDA for Xalkori 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 01/13/21 Siga Technologies: Meridian Medical to purchase up to $33M of oral TPOXX BNTX BioNTech $103.17 / -1.805 (-1.72%) 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine 01/08/21 Pfizer, BioNTech COVID vaccine elicits antibodies that neutralize mutation 01/07/21 BioNTech reports publication of preclinical data on novel mRNA vaccine approach PFE BNTX PFE Pfizer $36.48 / -0.26 (-0.71%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $103.17 / -1.805 (-1.72%) 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE BNTX PFE Pfizer $36.48 / -0.26 (-0.71%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $103.17 / -1.805 (-1.72%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate 23 Jul 06 Feb PFE BNTX PFE Pfizer $36.48 / -0.26 (-0.71%) 01/20/21 Japan inks deal with Pfizer for COVID vaccine for 72M people, Nikkei reports 01/20/21 Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports 01/18/21 NY Gov. asks Pfizer to directly sell COVID vaccine doses, Reuters reports 01/12/21 Pfizer, health officials investigating post-vaccine fatality, Bloomberg says BNTX BioNTech $103.17 / -1.805 (-1.72%) 01/04/21 Pfizer, BioNTech offered South Africa discounted vaccines, Bloomberg says 12/30/20 Nurse tests positive for COVID-19 week after getting Pfizer vaccine, KGTV says 12/22/20 White House, Pfizer near deal for tens of millions of vaccine doses, WP says PFE BNTX PFE Pfizer $36.48 / -0.26 (-0.71%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $103.17 / -1.805 (-1.72%) 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX PFE Pfizer $36.48 / -0.26 (-0.71%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th BNTX BioNTech $103.17 / -1.805 (-1.72%) 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th 11/02/20 Largest borrow rate increases among liquid names
Periodicals	Unilever says its suppliers must pay staff 'living wage,' BBC says » 19:11 01/20/21 01/20 19:11 01/20/21 19:11 UL Unilever $59.58 / +0.15 (+0.25%) Unilever said that, by… Unilever said that, by 2030, it will no longer do business with any company that does not pay at least a living wage or income to its employees, BBC News reports. The company defined a living wage as one that covered a family's basic needs "and helped them break the cycle of poverty," with the owner of Ben & Jerry's adding that it seeks to raise pay for people outside its own workforce, the report says. "Our ambition is to improve living standards for low-paid workers worldwide," Unilever said. "We will therefore ensure that everyone who directly provides goods and services to Unilever earns at least a living wage or income, by 2030." Reference Link ShowHide Related Items >><< Company News Street Research Periodicals On The Fly UL Unilever $59.58 / +0.15 (+0.25%) 12/21/20 Dada Nexus, Unilever announce new strategic partnership 12/18/20 Unilever to end advertising pause on Facebook, Twitter in U.S. in January 11/30/20 Unilever completes unification of group legal structure 11/25/20 Unilever to acquire SmartyPants Vitamins, terms not disclosed UL Unilever $59.58 / +0.15 (+0.25%) 12/08/20 Investec Unilever upgraded to Buy from Hold at Investec 12/03/20 Societe Generale Unilever initiated with a Buy at Societe Generale 11/25/20 Jefferies Jefferies sees 'strong buying opportunity' upcoming after Unilever unification 10/23/20 Investec Unilever downgraded to Hold from Buy at Investec UL Unilever $59.58 / +0.15 (+0.25%) 01/13/21 Unilever CEO encourages employees to get COVID vaccine, Reuters says 11/30/20 Unilever testing out four-day work week in New Zealand, Reuters says 11/17/20 Unilever targets EUR1B in sales from plant-based products by 2027, FT reports 09/11/20 Unilever South Africa sets up advisory board after 'racist' ad, Reuters says UL Unilever $59.58 / +0.15 (+0.25%) 09/02/20 Neptune Wellness CEO talks Unilever partnership in Fly exclusive interview

Hot Stocks	Eastman Kodak rises over 7% after Pigment.inc RDTG distribution deal » 19:01 01/20/21 01/20 19:01 01/20/21 19:01 KODK Eastman Kodak $9.02 / +0.175 (+1.98%) Shares of Kodak are up… Shares of Kodak are up 7.6% at $9.72 after-hours, with the company having announced a partnership with Pigment.inc B.V Europe to distribute Kodak's KODACOLOR RDTG Series Direct to Garment inks earlier today. The company states: "The KODACOLOR RDTG Series inks from Kodak were specifically developed for direct-to-fabric printing on cotton, cotton blends, and polyester fabrics. They are equally adept at printing direct to finished garments or to roll fabrics. This water-based ink system is designed to work in digital printers that employ piezo-electric printheads and operate at a very high level of nozzle performance among printheads requiring mid-to-high viscosity inks. Although designed for use in production printing, it is suitable for high quality sampling and strike offs."Reference Link ShowHide Related Items >><< Company News Earnings Periodicals On The Fly Options KODK Eastman Kodak $9.02 / +0.175 (+1.98%) 12/07/20 Eastman Kodak rises 56.2% 12/07/20 Eastman Kodak rises 83.3% 12/07/20 Eastman Kodak rises 76.2% 12/07/20 Kodak soars 71% to $12.86 after WSJ report on loan probe outcome KODK Eastman Kodak $9.02 / +0.175 (+1.98%) 11/10/20 Eastman Kodak report Q3 net loss ($445M) vs. ($5M) last year 08/11/20 Eastman Kodak reports Q2 operational EBITDA ($7M) vs. ($1M) last year KODK Eastman Kodak $9.02 / +0.175 (+1.98%) 12/07/20 Watchdog finds no wrongdoing in Kodak deal, WSJ reports 11/11/20 Former Kodak execs sold stock options they did not own, WSJ reports 10/19/20 Kodak will still work on making drug ingredients, CEO says at WSJ Tech Live 09/17/20 House Democrats questions findings of Kodak internal review, CNBC reports KODK Eastman Kodak $9.02 / +0.175 (+1.98%) 12/07/20 Fly Intel: Wall Street's top stories for Monday 12/07/20 Fly Intel: Wall Street's top stories at midday 12/07/20 Fly Intel: Pre-market Movers 11/10/20 Fly Intel: After-Hours Movers KODK Eastman Kodak $9.02 / +0.175 (+1.98%) 01/19/21 Kodak call volume above normal and directionally bullish 01/14/21 Heavy trading in Kodak calls and shares as stock lifts 7% 12/29/20 Kodak call volume above normal and directionally bullish 12/17/20 Kodak call volume above normal and directionally bullish
Downgrade	Allete downgraded to Neutral from Buy at Guggenheim » 18:54 01/20/21 01/20 18:54 01/20/21 18:54 ALE Allete $69.08 / +0.27 (+0.39%) Guggenheim analyst… Guggenheim analyst Shahriar Pourreza downgraded Allete to Neutral from Buy with a $66 price target. ShowHide Related Items >><< Company News Street Research Earnings Events ALE Allete $69.08 / +0.27 (+0.39%) 12/22/20 Allete's Diamond Spring wind site starts commercial operations 12/07/20 Allete announces renewable energy agreement with McDonald's ALE Allete $69.08 / +0.27 (+0.39%) 08/26/20 Mizuho Allete price target lowered to $55 from $66 at Mizuho 04/02/20 Sidoti Allete downgraded to Neutral from Buy at Sidoti 03/03/20 Mizuho Allete upgraded to Neutral from Underperform at Mizuho ALE Allete $69.08 / +0.27 (+0.39%) 11/09/20 Allete sees FY20 adjusted EPS $3.25-$3.45, consensus $3.33 11/09/20 Allete reports Q3 EPS 78c, consensus 64c 08/05/20 Allete sees 2020 adjusted EPS $3.25-$3.45, consensus $3.36 08/05/20 Allete reports Q2 EPS 39c with items, consensus 67c 02/17/21 Allete - ALE
Upgrade	Spire upgraded to Buy from Neutral at Guggenheim » 18:53 01/20/21 01/20 18:53 01/20/21 18:53 SR Spire $60.70 / -0.4 (-0.65%) Guggenheim analyst… Guggenheim analyst Shahriar Pourreza upgraded Spire to Buy from Neutral with a $72 price target. ShowHide Related Items >><< Company News Street Research Earnings Events SR Spire $60.70 / -0.4 (-0.65%) 11/18/20 Spire raises quarterly dividend to 65c from 62.25c per share SR Spire $60.70 / -0.4 (-0.65%) 12/09/20 UBS Spire initiated with a Buy at UBS 11/11/20 Sidoti Spire downgraded to Neutral from Buy at Sidoti 10/23/20 Credit Suisse Spire upgraded to Outperform from Neutral at Credit Suisse 09/30/20 Fly Intel: Top five analyst upgrades SR Spire $60.70 / -0.4 (-0.65%) 11/18/20 Spire narrows long-term economic EPS growth target to 5%-7% from 4%-7% 11/18/20 Spire sees FY21 economic EPS $4.00-$4.20, consensus $4.04 11/18/20 Spire reports Q4 economic EPS (37c), consensus (41c) 08/05/20 Spire sees FY20 economic EPS $3.70-$3.75, consensus $3.71 02/04/21 Spire - SR 01/28/21 Spire Inc.
Downgrade	Hawaiian Electric downgraded to Sell from Neutral at Guggenheim » 18:53 01/20/21 01/20 18:53 01/20/21 18:53 HE Hawaiian Electric $34.59 / +0.48 (+1.41%) Guggenheim analyst… Guggenheim analyst Shahriar Pourreza downgraded Hawaiian Electric to Sell from Neutral with a $30 price target. ShowHide Related Items >><< Company News Earnings Events HE Hawaiian Electric $34.59 / +0.48 (+1.41%) 09/16/20 Hawaiian Electric submits eight renewable energy projects to regulators HE Hawaiian Electric $34.59 / +0.48 (+1.41%) 08/06/20 Hawaiian Electric reports Q2 EPS 45c, consensus 37c 03/01/21 26th Annual Energy Virtual Summit 02/16/21 Hawaiian Electric - HE
Upgrade	American Electric upgraded to Buy from Neutral at Guggenheim » 18:52 01/20/21 01/20 18:52 01/20/21 18:52 AEP American Electric $80.78 / +0.03 (+0.04%) Guggenheim analyst… Guggenheim analyst Shahriar Pourreza upgraded American Electric to Buy from Neutral with a $93 price target. ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events AEP American Electric $80.78 / +0.03 (+0.04%) 12/09/20 American Electric names Daryl Roberts to board of directors 10/29/20 American Electric signs PPA for output from new 200 MW wind project in Ohio 10/26/20 American Electric to purchase 50 MW output from Columbus Solar Park 10/20/20 American Electric increases quarterly dividend to 74c per share AEP American Electric $80.78 / +0.03 (+0.04%) 01/14/21 Goldman Sachs American Electric downgraded to Sell from Neutral at Goldman Sachs 01/12/21 Fly Intel: Top five analyst downgrades 01/12/21 KeyBanc American Electric downgraded to Sector Weight at KeyBanc 01/12/21 KeyBanc American Electric downgraded to Sector Weight from Overweight at KeyBanc AEP American Electric $80.78 / +0.03 (+0.04%) 11/06/20 American Electric backs FY21 ops EPS view $4.51-$4.71, consensus $4.66 10/22/20 American Electric backs FY20 EPS $4.25-$4.45, consensus $4.32 10/22/20 American Electric reports Q3 EPS $1.47, consensus $1.45 08/06/20 American Electric backs FY20 EPS $4.25-$4.45, consensus $4.28 AEP American Electric $80.78 / +0.03 (+0.04%) 07/27/20 American Electric funded campaign involved in HB6 scandal, Dispatch says 02/25/21 American Electric - AEP

Events

Earnings calls, analyst events, roadshows and more

SDVKY
Today at 04:00

Sandvik AB - SDVKY Conference Calls
SI
Today at 08:00

Silvergate Capital - SI Conference Calls
BEDU
Today at 08:00

Bright Scholar - BEDU Conference Calls
DFS
Today at 08:00

Discover - DFS Conference Calls
WNS
Today at 08:00

WNS Holdings - WNS Conference Calls
TAL
Today at 08:00

TAL Education - TAL Conference Calls
STL
Today at 08:00

Sterling Bancorp - STL Conference Calls
TFC
Today at 08:00

Truist Financial - TFC Conference Calls
CTXS
Today at 08:15

Citrix - CTXS Conference Calls
PLXS
Today at 08:30

Plexus - PLXS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer $8.50-9.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG $5.76 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Canadian Western Bank price target raised to C$33 from C$29 at Scotiabank

TODAY'S FREE FLY STORIES

Get Full Fly Access